To further test whether TFAM expression is elevated in the tumor tissues and to determine its association with clinical and pathologic parameters of NSCLC patients, we performed IHC in TMA containing 150 archived paraffin-embedded NSCLC specimens. This evidence concerns the gene TFAM and non-small cell lung carcinoma.